CHARACTERISATION OF CHANGES IN LYMPHOCYTE SUBSETS IN BARICITINIB-TREATED PATIENTS WITH RHEUMATOID ARTHRITIS IN TWO PHASE 3 STUDIES

被引：6

作者：

Emery, P. ^{[1
]}

McInnes, I. ^{[2
]}

Genovese, M. C. ^{[3
]}

Smolen, J. S. ^{[4
]}

Kremer, J. ^{[5
]}

Dougados, M. ^{[6
]}

Schlichting, D. E. ^{[7
]}

Rooney, T. ^{[7
]}

Issa, M. ^{[7
]}

de Bono, S. ^{[7
]}

Macias, W. L. ^{[7
]}

Rogai, V. ^{[7
]}

Zuckerman, S. H. ^{[7
]}

Taylor, P. C. ^{[8
]}

机构：

[1] Univ Leeds, Div Rheumat & Musculoskeletal Dis, Leeds, W Yorkshire, England

[2] Glasgow Biomed Res Ctr, Glasgow, Lanark, Scotland

[3] Stanford Univ, Sch Med, Div Immunol Rheumatol, Stanford, CA 94305 USA

[4] Med Univ Vienna, Dept Rheumatol, Vienna, Austria

[5] Albany Med Coll, Albany, NY 12208 USA

[6] Paris Descartes Univ, Cochin Hosp, Paris, France

[7] Eli Lilly & Co, Indianapolis, IN 46285 USA

[8] Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Kennedy Inst Rheumatol, Oxford, England

来源：

关键词：

D O I：

10.1136/annrheumdis-2016-209124.147

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

A7.16

引用

页码：A62 / A62

页数：1